Oxford BioMedica PLC | Ownership
Companies that own Oxford BioMedica PLC
Vulpes Investment Management Pte Ltd.
11,620,169
17.67%
2,000
78.84%
09/15/2017
M&G Investment Management Ltd.
11,176,513
17%
-8,221
0.2%
09/19/2017
Aviva Investors Global Services Ltd.
4,131,751
6.28%
-1,374,017
0.1%
02/16/2018
Hargreaves Lansdown Asset Management Ltd.
2,682,540
4.08%
116,160
0.39%
03/02/2018
TD Direct Investing (Europe) Ltd.
1,927,593
2.93%
172,763
13.59%
02/15/2017
Hargreave Hale Ltd.
1,779,860
2.71%
775,620
0.22%
03/02/2018
European Investment Management Ltd.
1,495,240
2.27%
0
21.42%
03/02/2018
Tredje AP-fonden
1,409,573
2.14%
-105,000
0.12%
06/30/2017
Legal & General Investment Management Ltd.
1,114,580
1.7%
-126,180
0.01%
03/02/2018
FIL Investment Advisors (UK) Ltd.
680,400
1.03%
473,320
0.01%
03/02/2018
| Address |
Windrush Court
Oxford Oxfordshire OX4 6LT
United Kingdom
|
|
Employees
|
- |
| Website |
http://oxfordbiomedica.co.uk |
| Updated |
07/08/2019 |
| Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. It operates through the Platform and Product segment. |
